Results 251 to 260 of about 2,570,930 (351)

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Two-dimensional speckle-tracking echocardiography for evaluating left atrial remodeling in renal transplant recipients. [PDF]

Quant Imaging Med Surg
Li Y, Gan S, Zhou Y, Deng W, Pan S, Liang S, Ou A, Xu L.   +7 more
europepmc   +1 more source

Rising Inpatient Demands for Inherited Metabolic Disorders: Impact on Pediatric Capacity

American Journal of Medical Genetics Part A, EarlyView.
Maria Paula Silva, Kirsten Havens, Katherine Arduini, Anne Kozek, Erika Vucko, Joel Charrow, Joshua Baker, Carlos E. Prada   +7 more
wiley   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

WCN24-1028 IMPACT OF HEMODIALYSIS ACCESS ON EARLY POST-TRANSPLANT OUTCOMES AMONG LIVE-RELATED RENAL ALLOGRAFT RECIPIENTS

Kidney International Reports
D.H.A.R.S.H.A.N. RANGASWAMY, S.H.A.N.K.A.R. PRASAD NAGARAJU, D.I.V.Y.A. DATTA, M.O.H.A.N. BHOJARAJA, R.A.V.I.N.D.R.A. PRABHU ATTUR, I.N.D.U. RAO, S.R.I.N.I.V.A.S. VINAYAK SHENOY   +6 more
doaj   +1 more source

A Decade Long Struggle: A Young Man's Journey From Renal Transplant to Fatal Refractory Ascites. [PDF]

Cureus
Zahid SI, Zahid NI, Zahid MI, Zahid I.
europepmc   +1 more source

Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Tacrolimus dosing in the early post‐kidney transplant period is challenging due to a narrow therapeutic index and substantial interindividual pharmacokinetic (PK) variability. This study aimed to develop and validate mechanism‐informed machine learning (ML) models to support individualized tacrolimus dosing during this critical period ...
Hui Yu, Zihan Qin, Logan S. Smith, Jeong M. Park, Hao‐Jie Zhu   +4 more
wiley   +1 more source

Use of HLA desensitization in the management of renal transplant recipients in Europe. [PDF]

Front Immunol
Rostaing LPE, Böhmig GA, Taqi MM, Gibbons B.   +3 more
europepmc   +1 more source

Fluconazole therapy in transplant recipients under FK506 therapy [PDF]

, 1994
Gonzalez-Pinto, I, Jain, A, Kusne, S, Manez, R, Martin, M, Silverman, D, Starzl, TE, Venkataramanan, R, Warty, V   +8 more
core  

Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Tacrolimus monitoring is generally performed in whole blood (WB). Most (>85%) of circulating tacrolimus is bound to red blood cells. During pregnancy, WB monitoring might be suboptimal because of physiological changes including increased plasma volume and decreased haematocrit.
Jildau R. Meinderts, Paola Mian, Frederike G. I. van Vilsteren, Karien M. H. van de Wetering, Jelmer R. Prins, Stefan P. Berger, Daan J. Touw, Margriet F. C. de Jong   +7 more
wiley   +1 more source